Medicines and Healthcare products Regulatory Agency

We need to look at enhancing what already exists, rather than reinventing.

I think it's wrong that the MHRA hasn't referred to the existing electronic medicines compendium made available by industry through Datapharm when laying out the background to this proposal - this is very misleading to the public who will think it's a new idea, rather than something which already exists.

Who will pay for this proposed new database? Presumably the pharma industry in some form through increased fees to the MHRA. If so, and industry then ceases to fund the electronic medicines compendium, what would happen to the excellent Medicines Guides also produced by Datapharm (see http://medguides.medicines.org.uk/)? They would potentially be the casualty.